Understanding Islet Cell Transplantation for Type 1 Diabetes

Type 1 diabetes is a chronic autoimmune condition in which the immune system attacks and destroys the insulin-producing beta cells within the pancreatic islets of Langerhans. Without these cells, the body cannot regulate blood glucose, requiring lifelong exogenous insulin therapy. Despite advances in insulin analogs, continuous glucose monitors, and smart pumps, many patients still struggle with glycemic variability, hypoglycemic unawareness, and life-threatening complications. Islet cell transplantation offers a biological alternative: the infusion of donor-derived islets into the recipient’s liver, where they engraft and restore endogenous insulin secretion in response to glucose fluctuations.

This procedure is not a first-line therapy. It is reserved for individuals with severe, brittle type 1 diabetes who experience recurrent severe hypoglycemia or marked glycemic instability despite optimized medical management. Unlike whole-pancreas transplantation, islet transplantation is a minimally invasive procedure performed under local anesthesia and sedation, with a shorter hospital stay and lower surgical risk. However, it is not a cure. Recipients must commit to lifelong immunosuppression to prevent graft rejection and recurrence of autoimmunity, which carries its own set of risks and side effects. The goal is to achieve stable glucose control, reduce or eliminate hypoglycemic events, and improve quality of life.

The Evolution of Islet Transplantation: From Research to Clinical Therapy

The first successful islet transplant in humans was reported in 1989 by a team at the University of Alberta. The Edmonton Protocol, introduced in 2000, revolutionized the field by using a steroid-free immunosuppressive regimen (sirolimus, tacrolimus, and daclizumab) that dramatically improved insulin independence rates. Since then, advances in islet isolation techniques, purification, and culture have increased graft survival. Today, numerous centers worldwide perform islet transplantation under standardized protocols. The procedure remains an area of active research, with studies exploring alternative immunosuppression, encapsulated islets to avoid rejection, and stem-cell-derived beta cells. Staying current with these developments is important when selecting a center, as centers involved in research may offer access to novel protocols.

Why Certification Matters: Ensuring Quality and Safety

Not all centers offering islet cell transplantation meet the same standards. Certification by recognized bodies ensures that a center adheres to rigorous protocols for donor selection, islet isolation, quality control, patient selection, and post-transplant follow-up. In the United States, the Organ Procurement and Transplantation Network (OPTN), operated by the United Network for Organ Sharing (UNOS) under contract with the Health Resources and Services Administration (HRSA), sets criteria for transplant center certification. Centers must demonstrate adequate volume, satisfactory patient and graft survival rates, and compliance with national guidelines.

Additionally, the Foundation for the Accreditation of Cellular Therapy (FACT) provides accreditation specifically for cellular therapy programs, including islet isolation facilities. FACT accreditation verifies that every step in the process—from organ procurement and islet isolation to quality control, storage, and infusion—meets international standards. This accreditation is considered the gold standard for islet cell transplant programs. Choosing a FACT-accredited center reduces risks such as infection, graft failure, and complications from immunosuppression, and increases the likelihood of achieving sustained insulin independence and improved glycemic control.

Step-by-Step Guide to Locate a Certified Islet Cell Transplant Center Near You

Finding a certified center requires systematic research and collaboration with your diabetes care team. Use the following methods to identify reputable programs.

1. Consult the American Diabetes Association (ADA)

The ADA provides resources for patients seeking specialized diabetes care. While not a direct directory of transplant centers, the ADA partners with accrediting organizations and can offer guidance. Visit diabetes.org and search for “islet cell transplant” or call their helpline. They may direct you to certified programs or affiliated hospitals.

2. Use the UNOS Transplant Center Database

The United Network for Organ Sharing (UNOS) operates the most comprehensive database of U.S. transplant centers. Their website, unos.org, includes a search tool that allows you to filter by organ type (pancreas islet) and geographic location. Each listing displays certification status, transplant volume, and contact information. You can also review outcome data, such as one-year graft survival rates, to compare centers. This is the most reliable starting point.

3. Check the NIH Clinical Trials Registry

Many islet transplant centers participate in clinical trials funded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). The ClinicalTrials.gov database lists ongoing studies, including those investigating new immunosuppressive regimens, encapsulated islets, or stem cell therapies. Even if you are not enrolling in a trial, this registry can help you identify centers actively engaged in research and likely to have experienced teams.

4. Speak with Your Endocrinologist or Diabetes Specialist

Your primary diabetes care provider is an invaluable resource. Specialists often have professional networks and know which centers have strong reputations. They can also help assess your medical eligibility—factors such as age, kidney function, cardiac health, and the presence of antibodies—before you make referrals. Coordinate with them to ensure you meet basic candidacy criteria.

5. Contact Major Academic Medical Centers

Large university hospitals and academic medical centers often house multidisciplinary transplant programs with dedicated islet cell units. Notable examples include the University of Minnesota Medical Center, the University of California San Francisco, the University of Chicago Medicine, and the Mayo Clinic. Visit their websites for accreditation information, patient outcomes, and contact details. Many provide detailed sections on islet transplantation, including eligibility criteria and step-by-step guides for patients.

6. Leverage Patient Advocacy Organizations

Groups such as JDRF (Juvenile Diabetes Research Foundation) and Beyond Type 1 offer resources and community support. Their websites may list partner centers or provide directories of transplant facilities. Additionally, online forums and social media groups (e.g., on Facebook or Reddit) can connect you with patients who have undergone the procedure, offering firsthand insights into their experiences with specific centers.

Key Criteria for Evaluating Transplant Centers

Once you have identified potential centers, systematically evaluate them against the following criteria to make an informed decision. This checklist ensures you consider all critical factors.

  • Accreditation Status: Confirm FACT accreditation for islet isolation (ask for the most recent survey date) and OPTN/UNOS certification for the transplant program. These are non-negotiable indicators of quality.
  • Team Experience: Inquire about the number of islet cell transplants performed annually and cumulatively. Ask about the qualifications of the surgeons, interventional radiologists, and endocrinologists involved. Experience correlates with better outcomes.
  • Graft Success Rates: Centers should transparently report metrics such as insulin independence rates at one year, graft survival (defined by detectable C-peptide), and rates of hypoglycemia resolution. Look for peer-reviewed publications or center-specific outcome data.
  • Comprehensive Care Model: Does the center offer integrated pre-transplant evaluation, psychosocial support, nutritional counseling, and structured long-term follow-up? A multidisciplinary approach improves patient adherence and outcomes.
  • Immunosuppression Protocols: Understand the standard drugs used (e.g., tacrolimus, mycophenolate, sirolimus) and how the center manages side effects. Centers that customize protocols based on individual patient profiles tend to have better tolerability.
  • Financial Counseling: Transplant costs can be substantial. A certified center should have dedicated financial counselors to help with insurance pre-authorization, Medicare/Medicaid coverage, and potential assistance programs. Ask about out-of-pocket costs and financial aid options.
  • Research Involvement: Centers engaged in clinical trials or research may offer access to novel therapies such as steroid-free regimens, encapsulated islets, or combination immunotherapies. This can be an advantage if conventional options are limited.
  • Patient Support Services: Ask about support groups, peer mentoring programs, and transplant alumni networks. Connecting with others who have undergone the procedure can provide emotional support and practical advice.

Questions to Ask During Your Consultation

Prepare a detailed list of questions to ask during initial consultations with transplant coordinators or physicians. Examples include:

  • Is your islet isolation laboratory FACT-accredited? When was the most recent accreditation survey?
  • What is your center’s one-year patient survival and graft survival rate for islet transplantation? How do you define graft failure?
  • How does your team handle donor organ allocation and waitlist management? What is the typical waiting time from evaluation to transplant?
  • What pre-transplant testing is required? This typically includes kidney function, cardiac clearance, liver assessment, and psychological evaluation.
  • What are the most common side effects of immunosuppression experienced by your patients? How do you monitor for and manage them?
  • Do you offer support groups or connect patients with alumni who have undergone the procedure? Can I speak with a former patient?
  • What happens if the first transplant fails? Do you offer retransplantation? What are the criteria for that?
  • Are there any ongoing clinical trials that I might be eligible for? If so, how do they differ from standard protocols?
  • What is the protocol for long-term follow-up? How frequently will I need to be seen, and what monitoring tests are done?

Risks and Benefits of Islet Cell Transplantation

Benefits

The primary benefit is a marked improvement in glycemic control with a reduction in severe hypoglycemic events. Many patients achieve insulin independence for months to years, and even partial graft function can lead to better HbA1c levels and reduced diabetic complications. Quality of life often improves significantly: patients report less anxiety about hypoglycemia, more flexibility in diet and exercise, and reduced burden of daily diabetes management. Long-term outcomes from centers like the University of Alberta show that more than 50% of recipients maintain some degree of graft function at five years, with a subset remaining insulin-free.

Risks

Risks fall into three categories: procedural, immunosuppressive, and graft-related. Procedural risks include bleeding, portal vein thrombosis, and liver damage from the infusion. Immunosuppressive risks are significant and include increased susceptibility to infections, nephrotoxicity (especially from calcineurin inhibitors), hypertension, dyslipidemia, metabolic syndrome, and an elevated risk of certain cancers such as post-transplant lymphoproliferative disorder. Graft-related risks include primary nonfunction (the islets fail to engraft) or eventual loss due to chronic rejection, recurrence of autoimmunity, or toxicity from immunosuppression. Patients may need to continue some insulin if graft function is partial. A thorough pre-transplant evaluation helps minimize these risks by identifying contraindications such as severe renal impairment, active infections, or malignancy.

Alternatives to Islet Cell Transplant

For patients who are not candidates or prefer other approaches, consider the following options:

  • Whole Pancreas Transplant: Often performed simultaneously with a kidney transplant in patients with end-stage renal disease. It can provide durable insulin independence but involves a major surgical procedure with higher morbidity. It may be appropriate for select patients who also need a kidney transplant.
  • Advanced Insulin Delivery Systems: Modern insulin pumps paired with continuous glucose monitors and hybrid closed-loop systems (artificial pancreas) can achieve excellent glycemic control for many patients. These systems reduce hypoglycemia and improve time-in-range significantly. They are less invasive and carry no immunosuppression risks.
  • Stem Cell Therapies: Experimental approaches using stem-cell-derived beta cells (e.g., from embryonic or induced pluripotent stem cells) are under investigation. Clinical trials are ongoing, but as of 2025, no stem cell therapy is approved for routine use. Encapsulation devices to protect transplanted cells from immune attack are also being studied.
  • Immunotherapies: Drugs that modulate the immune system to preserve remaining beta cell function are being explored in recently diagnosed patients. Agents like teplizumab have shown promise in delaying progression of type 1 diabetes, but they do not reverse established disease. They are not a substitute for transplantation in advanced cases.

Preparing for an Islet Cell Transplant: The Workup and Waiting Period

Once you have selected a certified center and been deemed a candidate, the pre-transplant evaluation typically includes:

  • Comprehensive medical history and physical examination
  • Blood tests to assess kidney function (creatinine, eGFR), liver function, and immune status (autoantibodies, HLA typing)
  • Serology for infectious diseases: HIV, hepatitis B and C, cytomegalovirus (CMV), Epstein-Barr virus (EBV)
  • Cardiopulmonary evaluation: electrocardiogram (ECG), echocardiogram, and possibly a stress test to ensure cardiac fitness
  • Psychosocial assessment to evaluate readiness for lifelong immunosuppression, adherence to medications, and social support
  • Dental clearance and vaccination updates (pneumococcal, influenza, COVID-19, etc.)

After clearance, you are placed on the UNOS waitlist. Wait times vary based on blood type, antibody sensitization, and donor availability. During the wait, maintain close contact with your transplant coordinator, keep your medical status current, and continue optimal diabetes management. Some centers may also require periodic re-evaluations.

Cost and Insurance Considerations

Islet cell transplantation is an expensive procedure. In the United States, costs can exceed $100,000 for the transplant alone, excluding ongoing immunosuppression and follow-up. Medicare covers islet transplantation for eligible patients at approved centers, but private insurance coverage varies. A certified center’s financial counseling team should help you navigate pre-authorization, understand copayments and deductibles, and identify assistance programs (e.g., from pharmaceutical companies or nonprofit organizations). Always confirm coverage before proceeding.

Conclusion: Taking the Next Step

Finding a certified islet cell transplant center is a critical first step toward potentially life-changing diabetes treatment. By leveraging resources from the American Diabetes Association, UNOS, clinical trial registries, and your healthcare team, you can identify centers that meet stringent quality standards. Ask the right questions, evaluate their outcomes, and weigh both the benefits and risks. With careful planning and expert care, islet cell transplantation can offer renewed freedom from constant blood sugar management and severe hypoglycemia.

Remember to consult with your diabetes care team before making any decisions. Each patient’s situation is unique, and a certified center’s team will help determine if you are a suitable candidate. Start your search today by visiting UNOS or the American Diabetes Association to find a center near you. For more information on accreditation standards, visit the FACT website.